January 25, 2012
Zalicus Inc. on Wednesday said Covidien PLC, with which it partners on Covidien's painkiller Exalgo, has agreed to a settlement with Watson Pharmaceuticals Inc. that will allow a generic version of Exalgo to hit the market before the expiration of Covidien's patent.
December 15, 2010
A Covidien PLC subsidiary has sued specialty pharmaceutical company Watson Pharmaceuticals Inc. in an effort to stop it from marketing a generic version of painkiller Exalgo.